Jorge Rico-Fontalvo
10PUBLICATIONS
95CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Mar 18, 2026
Renal Outcomes of GLP-1 Receptor Agonists and Tirzepatide Across CKD Stages and Metabolic Phenotypes (Type 2 Diabetes and/or Overweight/Obesity): A Scoping Review.Jorge Rico-Fontalvo, Rodrigo Daza-Arnedo, Alicia Elbert
|Jul 29, 2025
Obesity-Related Kidney Disease: A Growing Threat to Renal Health.Juan León-Román, Marina López-Martínez, Alexandra Esteves
|Jun 02, 2025
Candidate Interventions for Integrating Hypertension and Cardiovascular-Kidney-Metabolic Care in Primary Health Settings: HEARTS 2.0 Phase 1.Andres Rosende, Cesar Romero, Donald J DiPette
|Dec 16, 2024
Author's Reply to Peronard and Mayntz: "SGLT2 Inhibitors, and How They Work Beyond the Glucosuric Effect".David Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera-Martínez
|Nov 08, 2024
Kidney effects of Glucagon-Like Peptide 1 (GLP1): from molecular foundations to a pharmacophysiological perspective.Jorge Rico-Fontalvo, Maricely Reina, María José Soler
|Aug 23, 2024
SGLT2 Inhibitors and How They Work Beyond the Glucosuric Effect. State of the Art.David Aristizábal-Colorado, Martín Ocampo-Posada, Wilfredo Antonio Rivera-Martínez
Pageof 2
Frequent Collaborators
3 joint publications
Jose Cabrales
3 joint publications
María Cristina Martínez-Ávila
3 joint publications
Rodrigo Daza-Arnedo
2 joint publications
Tomas Yánez-Rodríguez
2 joint publications
Juan Esteban Gómez-Mesa
2 joint publications
John Jairo Duque-Ossman
2 joint publications
David Corredor-Rengifo
2 joint publications
Wilfredo Antonio Rivera-Martínez
2 joint publications
Martín Ocampo-Posada
2 joint publications
David Aristizábal-Colorado
